Table 1. Patient participant questionnaire content.

Trial assessments	Baseline	2-week	3-month
Demographics (date of birth, sex at birth)	✓	✓ *	✓ *
Employment status	✓
Marital status	✓
Fracture occurrence including site and date	✓		✓
Fracture risk factors:
•  self-reported height	✓
•  rheumatoid arthritis	✓
•  family history	✓
•  secondary causes see FRAX https://www.sheffield.ac.uk/FRAX/)	✓
Ethnicity	✓
Health literacy 25	✓
Barriers to communication (hearing, vision) and first language	✓
Digital access	✓
Experience of osteoporosis medicine	✓
Socioeconomic status (IMD)	✓
Beliefs about medicines (BMQ-general) 27	✓
Primary outcome
Decisional conflict 26		✓
Secondary outcome measures for all
Modified Patient-Professional Interaction Questionnaire (PPIQ) 28 (see extended data)		✓
Satisfaction with verbal information 29 and experience		✓
Recall of, and satisfaction with written information 29			✓
Recall of consultation – including key elements included in the training, being shown the computer, receiving diagnosis, receiving drug recommendation		✓
Modified Brief Illness Perceptions Questionnaire 30 (see extended data)	✓	✓	✓
Self-reported change in physical activity			✓
Worry about further falls and fractures 31	✓	✓
Self-perceived fracture risk 32	✓	✓
Self-reported weight	✓		✓
Alcohol	✓		✓
Smoking	✓		✓
Secondary outcomes: Recommended medication only
Beliefs about medicines (BMQ-specific) 27			✓
Satisfaction with medicines information (SIMS) 33		✓
Osteoporosis specific values		✓
Self-reported medicine initiation or intention to initiate		✓	✓
Self-reported adherence 34 and, persistence or discontinuation with medicine			✓
Medicine self-reported side effects	✓		✓
Health Economic Outcomes
Health status – EQ-5D-5L 35	✓	✓	✓
Health care utilisation	✓		✓

*date of birth and sex at birth collected to verify identity at 2 weeks and 3 months